Posted on 07/18/2011 5:42:41 PM PDT by markomalley
Nabi Biopharmaceuticals said Monday that its experimental anti-smoking vaccine NicVAX did not meet its main goal in a late-stage test, sending the company's shares plunging.
The company said about 11 percent of patients who were received a dummy shot were able to quit smoking, and patients who were treated with NicVAX quit at a similar rate. Nabi said it is evaluating the data and waiting for results from a second late-stage study.
"We are clearly surprised and deeply disappointed with the results of this first NicVAX Phase III trial," said President and CEO Raafat Fahim.
(Excerpt) Read more at finance.yahoo.com ...
Hey, go into the placebo business!
Earlier ABC news had a story that second hand smoke could make your teen go deaf. So now I know why I never listened to my chain smoking step Dad.
Nanny State PING!
The company is apparently in Rockville, Merlin.
Maryland “Freak State” PING!
Frickin idjits.
Not worth it unless you get those crazy Chantix dreams.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.